Conversely, Parkin overexpression not only reduces aging-related increases in markers of oxidative stress, fibrosis, and apoptosis, but also enhances mitochondrial content and enzymatic activities, mitigating sarcopenia and improving skeletal muscle performance [37]. The gene discussed is PRKN; the disease is sarcopenia.